VENTRINOVA
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNova’s first generation product is a gene therapy that delivers a critical mitotic regulator to diseased heart tissue to stimulate proliferation of cardiac muscle cells.
VENTRINOVA
Industry:
Clinical Trials Genetics Therapeutics
Founded:
2006-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ventrinovainc.com
Total Employee:
1+
Status:
Active
Contact:
508-362-3087
Total Funding:
1000 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Google Font API WordPress LetsEncrypt Font Awesome Mobile Non Scaleable Content IPv6 Cloudflare Hosting Wordpress Plugins
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Lannett Company
Lannett develops, manufactures, and distributes generic prescription pharmaceutical products in tablet.
Recensa Therapeutics
Recensa Therapeutics, Inc. has a new approach to treating psoriasis: targeting oxidative stress.
Current Advisors List
Investors List
Broadview Ventures
Broadview Ventures investment in Seed Round - Ventrinova
Official Site Inspections
http://www.ventrinovainc.com
- Host name: 104.21.50.97
- IP address: 104.21.50.97
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ventrinova"
Centre de médecine régénérative
Le Center for Regenerative Medicine étudie l'utilisation des thérapies cellulaires et des nouveaux biomatériaux pour le traitement des maladies et des blessures.See details»
Ventrinova - Crunchbase Company Profile & Funding
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNova’s …See details»
VentriNova - VentureRadar
Website: http://www.ventrinovainc.com/ Develops gene therapy targeting cyclin A2 delivery to promote regeneration and repair of cardiac muscles for improved heart function. VentureRadar …See details»
VentriNova Company Profile 2024: Valuation, Funding & Investors
Developer of regenerative medicines designed to provide clinical treatments and gene therapy for the regeneration of heart tissue.See details»
VentriNova Company Profile | Management and Employees List
Www.ventrinovainc.com VentriNova Profile and History VentriNova is a preclinical stage cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of …See details»
VentriNova - Overview, News & Similar companies | ZoomInfo.com
View VentriNova (www.ventrinovainc.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much …See details»
Ventrinova: Contact Details and Business Profile - RocketReach
VentriNova is a preclinical stage cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart …See details»
VentriNova - Products, Competitors, Financials, Employees, …
VentriNova is a cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. …See details»
VentriNova Inc | www.inknowvation.com
Business Identifier: Clinical treatments and gene therapy for the regeneration of heart tissueSee details»
VentriNova, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore VentriNova, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
VentriNova, Inc. - Wiki | Golden
VentriNova, Inc. is a company by Hina W. Chaudhry, M.D. VentriNova specializes in cardiac regenerative medicine by reversing cardiac damage pharmacologically.See details»
VentriNova | CipherBio
Explore VentriNova's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
VentriNova, Inc. to present at TEDMED 2013 - PR Newswire
Apr 16, 2013 · /PRNewswire/ -- VentriNova, a cardiac regenerative medicine biotechnology company, announced today that Dr. Hina Chaudhry, Founder, will be presenting...See details»
VentriNova's Gene Therapy Strategy Regenerates Heart Muscle …
Feb 19, 2014 · VentriNova, a regenerative medicine company with a novel gene therapy product, announced today that the journal Science Translational Medicine has published the results of …See details»
Top cardiac regenerative therapy companies | VentureRadar
VentriNova is a regenerative medicine company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de novo heart muscle cells. VentriNova’s …See details»
VentriNova's Gene Therapy Strategy Regenerates Heart Muscle …
Feb 20, 2014 · VentriNova is a preclinical stage cardiac regenerative gene therapy company focused on reversing cardiac damage by activation of intrinsic repair pathways to generate de …See details»
Portfolio – Broadview Ventures
Comanche Biopharma is a preclinical biopharmaceutical company developing a novel siRNA therapy for the treatment of preeclampsia. The Company’s purpose is to lower the risks of …See details»
Research programme: CCNA2 gene therapy - VentriNova
VentriNova is developing viral vector-based gene therapies for the regeneration of cardiovascular tissue following myocardial infarction. The technology.See details»
VentriNova's Gene Therapy Strategy Regenerates Heart Muscle …
Feb 20, 2014 · NEW YORK, NY--(Marketwired - February 19, 2014) - VentriNova, a regenerative medicine company with a novel gene therapy product, announced today that the journal …See details»
Home - Broadview Ventures
Portfolio Name: CorFlow CorFlow is developing the first catheter-based technology designed to rapidly and accurately diagnose microvascular obstruction (MVO), and to deliver therapeutic …See details»